Navigation Links
Ex-PRESS Mini Glaucoma Shunt

ProductsEx-PRESS Mini Glaucoma Shunt
Company Optonol Ltd.
Item Ex-PRESS Mini Glaucoma Shunt
Features Benefits
  • Remarkably quiet eye
  • No iridectomy
  • No scleral tissue removal
  • Reduced inflammation
  • Reversible procedure & predictable results
  • Ideally performed following cataract surgery
Description The Ex-PRESS is a mini glaucoma shunt that provides a simplified method of filtration surgery for patients with open angle glaucoma. Similar to trabeculectomy, the shunt reduces the intraocular pressure, by diverting the aqueous humor from the anterior chamber to the subconjunctival space to form a filtration bleb.
Info Optonol Ltd.
Customer Service: (866) 765-7377
Web site: http://www.optonol.com

Related medicine products :

1. Baerveldt Glaucoma Implant
2. Baerveldt Pars Plan Glaucoma Implant
3. Ahmed Glaucoma Valve
4. Ahmed Glaucoma Valve Flexible Plate
5. Ahmed Glaucoma Valve (small size)
6. Ahmed Glaucoma Valve with Pars Plana Clip
7. Ahmed Glaucoma Valve (small size) with Pars Plana Clip
8. Ahmed™ Glaucoma Valve Bi-Plate
9. Selecta II Glaucoma Laser System
10. Selecta II Glaucoma Laser System
11. DeepLight Glaucoma Treatment System
... white LED (Light Emitting Diode) light source, coupled ... the freedom of using a slit lamp anywhere ... about 1.5 lbs. (0.68 kg) with its battery ... Its ergonomic, portable design and convenient carrying ...
Powerful LED Illumination , The ultrabright and compact 3S LED HeadLight from HEINE for Powerful, coaxial illumination...
... Abnormal Control Serum is intended for monitoring the ... assays. It is for in vitro diagnostic use ... format, the control offers up to ten days ... control is to be used in accordance with ...
e-MDs Bill practice management system is used in the medical billing cycle....
Medicine Products:
(Date:7/7/2015)... ... 07, 2015 , ... Nationally-renowned attorneys in the realm of ... Invokana Ketoacidosis Lawsuit Center . The website provides information on Invokana side ... wishing to learn more about Invokana lawsuits for kidney problems, ketoacidosis, heart attack, ...
(Date:7/7/2015)... ... July 07, 2015 , ... Clarion ... labels, has been featured in the latest issue of In Compliance Magazine, a ... In Compliance delivers the latest news, standards updates, technical explanations and guidance, ...
(Date:7/7/2015)... ... 2015 , ... CareSync proudly announces today that Amy Gleason, ... House as a “Champion of Change” for Precision Medicine on Wednesday, July 8th. ... Change program recognizes Gleason and eight other extraordinary individuals who are making great ...
(Date:7/7/2015)... ... 2015 , ... Each year the Holiday Inn Westbury donates many ... and international level; however, the Holiday Inn now hosts one large event at the ... the beneficiaries. In September of 2014 they hosted an event with all proceeds going ...
(Date:7/6/2015)... ... July 07, 2015 , ... Currently, mobile testing is ... AIDS, advances in the molecular diagnostic technologies, wide availability of immunosuppressive drugs and ... technologies and genetic engineering also open lucrative opportunities for the market players. , ...
Breaking Medicine News(10 mins):Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 2Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 3Health News:Standards Considerations for Laser Safety Labels from Clarion Safety Systems Featured in In Compliance Magazine 2Health News:Standards Considerations for Laser Safety Labels from Clarion Safety Systems Featured in In Compliance Magazine 3Health News:Standards Considerations for Laser Safety Labels from Clarion Safety Systems Featured in In Compliance Magazine 4Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 2Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 3Health News:The Holiday Inn Westbury - Long Island Will Host a Fundraising Event on September 16th 2015 from 6:00 pm - 10:00 pm to Benefit Angela's House located on Long Island 2Health News:The Holiday Inn Westbury - Long Island Will Host a Fundraising Event on September 16th 2015 from 6:00 pm - 10:00 pm to Benefit Angela's House located on Long Island 3Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 2Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 3
... Reporter , TUESDAY, July 27 (HealthDay News) -- Infants born ... breathing problems compared with full-term babies, a new study finds. ... and 37th weeks of pregnancy -- account for about 9 ... researchers said. And too often, they are the result of ...
... attention-deficit/hyperactivity disorder (ADHD) the most common childhood psychiatric ... to finish high school on time than students with ... a large national study by researchers at the UC ... that nearly one third of students with ADHD, twice ...
... News) -- Weight-loss surgery, also known as bariatric surgery, ... of serious complications, a new study suggests. The ... that do the highest number of bariatric surgeries, according to ... Journal of the American Medical Association . Rates ...
... H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus ... the California Institute of Technology, has been named winner ... Society (ACS). The award recognizes Zewail,s revolutionary methods ... processes in chemistry, biology and materials science. His work ...
... Reporter , MONDAY, July 26 (HealthDay News) -- Extending the ... tPA from 3 hours to up to 4.5 hours after ... in treatment and appears to be a safe option for ... slight increased risk of death and bleeding over a three-month ...
... July 26, 2010 A review of scientific studies that ... no clear answer on which treatment is better, a UT Southwestern ... the Archives of Internal Medicine . "The most ... be a mix of good and bad news," said Dr. Ethan ...
Cached Medicine News:Health News:Delivering Babies Even a Few Weeks Early Ups Respiratory Risks 2Health News:Delivering Babies Even a Few Weeks Early Ups Respiratory Risks 3Health News:ADHD, conduct disorder and smoking most strongly related to dropping out of high school 2Health News:ADHD, conduct disorder and smoking most strongly related to dropping out of high school 3Health News:ADHD, conduct disorder and smoking most strongly related to dropping out of high school 4Health News:Complications From Weight-Loss Surgery 'Relatively Low' 2Health News:American Chemical Society's highest honor goes to pioneer in 'ultraslow-motion' imaging 2Health News:American Chemical Society's highest honor goes to pioneer in 'ultraslow-motion' imaging 3Health News:Longer Time Frame for Clot-Busting Drug May Help Beat Stroke 2Health News:Longer Time Frame for Clot-Busting Drug May Help Beat Stroke 3Health News:Surgery or stenting for carotid artery disease? Question remains 2Health News:Surgery or stenting for carotid artery disease? Question remains 3
(Date:7/6/2015)... 2015 Celtaxsys, Inc., a clinical stage pharmaceutical ... rare and orphan inflammatory disease indications, announced today that ... Drug Administration (FDA) to begin a Phase 2 clinical ... adult CF patients in the US. The regulatory submissions ... will be filed soon after. This groundbreaking clinical ...
(Date:7/6/2015)... SOUTH SAN FRANCISCO, Calif. , July 6, 2015 ... leading global pharmaceutical company, and Oculeve, a development-stage medical ... eye disease, today announced that they have entered into ... an all-cash transaction.  Under the terms of the agreement, ... payment and commercialization milestone payments related to Oculeve,s lead ...
(Date:7/6/2015)... SHENZHEN, China , July 6, 2015 China ... CNIT), a leading provider of integrated cloud-based platform, exchange, ... , today announced that the Company launched its mobile ... age of accessible healthcare services on mobile devices. The ... District Health and Family Planning Bureau and Shenzhen News ...
Breaking Medicine Technology:Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3Allergan to Acquire Oculeve Dry Eye Disease Development Programs 2Allergan to Acquire Oculeve Dry Eye Disease Development Programs 3Allergan to Acquire Oculeve Dry Eye Disease Development Programs 4CNIT Launches the Mobile App for Healthcare One Pass 2CNIT Launches the Mobile App for Healthcare One Pass 3CNIT Launches the Mobile App for Healthcare One Pass 4